What this covers

This is a 21-minute clip from a longer FoundMyFitness conversation in which Peter Attia is the main voice, with an interviewer and another speaker interjecting. The speakers are labeled only generically in the transcript. The discussion treats ApoB as the particle that carries cholesterol into the artery wall, and it asks what that implies for management. Much of it is about what counts as a "normal" level. Standard lab ranges, the speaker says, reflect only population distribution (below 80 mg/dL, 80-120, above 120) and say nothing about optimal targets. Newborns, by contrast, have levels of roughly 10-30 mg/dL, which is enough to myelinate the central nervous system and build steroid tissue. Peter Libby of Brigham and Women's Hospital is cited for the view that atherosclerosis would be biochemically impossible below 20-30 mg/dL.

The middle of the clip covers biology and evolution. LDL, not HDL, does most reverse cholesterol transport in humans, and most animal species get by without ApoB or LDL at all. The speakers also discuss why cholesterol synthesis and VLDL production were conserved even though they no longer serve a purpose in an energy-abundant, antibiotic-era world. ApoB is said to rise with age mainly because clearance declines, probably through fewer or shorter-lived LDL receptors. The area under the curve framing holds that lifetime exposure matters, so someone who never exceeds 60 mg/dL fares better than someone brought down to 60 from 120. That claim is flagged as contested.

The diet section is where the clip turns contentious. Carbohydrate restriction is presented as the best way to lower triglycerides, and so ApoB. Saturated fat is presented as a second driver, with palmitic acid possibly more potent than longer-chain fats. The speaker rejects the low-carb view that high LDL on a ketogenic diet is benign, even though he describes three years on such a diet without a problematic rise. He also lists four causal drivers of ASCVD (ApoB, insulin resistance, hypertension, smoking) and says most people cannot reach ApoB below 30 mg/dL without medication.

Sharpest takeaway

ApoB is a causal driver of atherosclerotic cardiovascular disease that should be aggressively lowered regardless of percentile thresholds, similar to how we treat smoking, because atherosclerosis begins at birth and accumulates over decades as a function of lifetime ApoB exposure.

  • ApoB is causally linked to ASCVD, not merely associated, making percentile-based risk thresholds inappropriate for management
  • Children are born with physiologic ApoB levels of 10-30 mg/dL with enormous cholesterol demands for CNS myelination and growth, proving humans don't need high ApoB
  • The area under the curve of ApoB over a lifetime is what drives atherosclerosis risk, similar to pack-years of smoking, making early and continuous reduction essential

The claims · ranked23 claims · weighted by value

This asset isn't compiled yet

You're seeing its claims, ranked. Compile it to build the argument threads, weight them, and check each claim against your library — the full view.

0.80

LDL particles perform reverse cholesterol transport (RCT), which represents the 'good' movement of cholesterol back to the liver, and in humans LDL does the majority of reverse cholesterol transport, not HDL as commonly believed; HDL typically transfers its cholesterol to LDL particles which then return it to the liver.

factualhigh valueestablishednovelty 2/4durability 4/4· Unknown Speaker (Medical Professional)

“in US LDL is doing the majority of what's called reverse cholesterol transport so RCT which is kind of like the good movement of cholesterol you sort of think of the bad movement as taking cholesterol into the arteries the good movement is taking it back to the liver in US LDL is doing the majority of that so hdls are typically transferring their cholesterol to ldls and ldls are bringing them back to the liver”

0.80

Children are born with ApoB and LDL cholesterol levels typically below 20 mg/dL, and these 'physiologic levels' of 10-30 mg/dL are sufficient to meet all cholesterol demands including myelination of the entire central nervous system and steroidal tissue synthesis, demonstrating that humans require minimal ApoB for normal development and function.

factualhigh valueestablishednovelty 2/4durability 4/4· Unknown Speaker (Medical Professional)

“if you look at a child they're born with an LDL cholesterol or apob level typically below 20 milligrams per deciliter so a kid if you think about it has the greatest need for growth right like so you think about the cholesterol demand of myelinating the entire central nervous system all of the enormous uh explosion of steroidal tissue all of these things are done with lipoprotein levels that are incredibly low again what we call physiologic levels of LDL cholesterol and apob are on the order of 10 to 30 milligrams per deciliter and yet there are no negative consequences to such low levels of that lipoprotein burden”

0.76

Most animal species do not require ApoB or LDL for cholesterol transport; they accomplish equivalent transport using HDL alone, demonstrating that humans' dependence on ApoB/LDL is not a universal necessity but rather a species-specific trait that can be viewed as suboptimal in modern environments.

factualhigh valueestablishednovelty 2/4durability 4/4· Unknown Speaker 1

“most species don't have apob they don't require LDL but how I mean they have cholesterol but they don't they don't they don't require transporting all these you know you can do it with HDL you can transport everything with HDL”

0.75

Peter Libby, an authority on atherosclerosis from Brigham and Women's Hospital, has argued that an ApoB level below 20-30 mg/dL would make it biochemically impossible to develop atherosclerosis.

factualhigh valueestablishednovelty 2/4durability 3/4· Unknown Speaker (Medical Professional)

“Peter Libby um from the Brigham who's one of the authorities on this topic has has argued uh and I referen him in my book that if you had an apob level below about 30 milligrams per deciliter 20 to 30 milligrams per deciliter it wouldn't be possible to develop atherosclerosis”

0.75

Standard laboratory reference ranges for ApoB are based purely on population distribution: below 80 mg/dL represents the 20th percentile, 80-120 mg/dL is intermediate risk, and above 120 mg/dL is very high risk, but these ranges do not reflect optimal clinical targets.

factualhigh valueestablishednovelty 2/4durability 3/4· Unknown Speaker (Medical Professional)

“the Reference Lab we use we'll say APO B below 80 is wonderful well 80 just happens to be the 20th percentile of the population it will say 80 to 100 is intered or 80 to 120 it says is intermediate risk and above 120 is very high risk so in for the lab we use we know that 80 is the 20th percentile uh 120 is the 80th percentile or the 60th percentile”

0.74

The relationship between causality and disease is not bidirectional necessity: causality does not require that all people with the cause develop the disease (cigarettes do not cause lung cancer in every smoker) nor that all people with the disease had the cause (not all lung cancer occurs in smokers), yet this does not negate the causal relationship and should not change management strategy.

causalhigh valueestablishednovelty 1/4durability 4/4· Unknown Speaker (Medical Professional)

“causality doesn't mean everybody who smokes will get lung cancer and it doesn't mean that every person with lung cancer um smoked so you you don't need to be necessary and sufficient necessary or sufficient to still be causal but our approach to patients who smoke is very clear which is Never Smoke and if you do smoke stop immediately do we look at people who smoke and say well once your 10-year risk of lung cancer reaches this threshold we're going to tell you to stop smoking or once your pack year smoking is above the 50th percentile or the 80th percentile we're going to tell you to stop absolutely not you immediately eliminate smoking”

0.74

Atherosclerosis begins at birth and progresses over decades; autopsy studies of young people (e.g., a 26-year-old homicide victim) show advanced coronary artery atherosclerosis that is not yet clinically manifest, demonstrating that atherosclerosis is a lifelong disease where early control of ApoB has potential to prevent its progression.

factualhigh valueestablishednovelty 1/4durability 4/4· Unknown Speaker (Medical Professional)

“atherosclerosis begins at Birth um when you do autopsies on people who are very young in fact I in the book include a photo of a a guy who you know a man I forget I think maybe 26 years old who was a victim of a homicide or something so an completely unrelated death um but you look at the autopsy sections of his coronary arteries I mean he already had very Advanced atherosclerosis now it wasn't clinically relevant it wasn't going to kill him anytime soon but the point is this is a disease that takes decades to progress”

0.74

Elevated insulin and glucose levels, independent of their effects on triglyceride production, directly create problems at the endothelial level and contribute to atherosclerosis through additional mechanisms beyond ApoB and triglyceride pathways.

causalhigh valueestablishednovelty 1/4durability 4/4· Unknown Speaker (Medical Professional)

“insulin and glucose by themselves when elevated also create problems at the endothelial level which becomes another mechanism by which this is problematic”

0.72

The area under the curve (AUC) principle applied to ApoB means that lifetime cumulative ApoB exposure drives atherosclerotic risk, making the duration at which ApoB remains elevated as important as the absolute level; a person with lifetime ApoB never exceeding 60 mg/dL carries substantially lower risk than someone brought down from 120 to 60 mg/dL.

causalhigh valuecontestednovelty 2/4durability 4/4· Unknown Speaker (Medical Professional)

“so the first thing is how long are you at 60 so if you say I've never exceeded 60 that's very different from saying hey I showed up and I was at 120 and you now lowered me to 60... I imagine like everybody walks around and you've got a graph that on the x- axis is time and on the Y AIS is AP B and you have a curve and you want to figure out what the area under that curve is and that we want to minimize the area under that curve”

0.72

The speaker rejects the belief held by some in the low-carb community that elevated ApoB and LDL cholesterol resulting from high saturated fat intake on low-carb diets is benign or acceptable, arguing instead that if lipids become elevated even with other favorable metabolic parameters (insulin sensitivity, energy balance), this warrants close clinical attention and intervention.

normativehigh valuecontestednovelty 2/4durability 4/4· Unknown Speaker (Medical Professional)

“I'm not in the camp that believes that um and there is an entire Camp of people who believe this that if you're on a low carb high fat diet and your apob and ldlc go through the roof it's it's not problematic I I don't believe that at all I think that that's a very bold claim and I would not be willing to play that game I think if your apob goes Haywire even if you're very insulin sensitive and even if you're in energy balance and all the other wonderful things that might come with your uh with your you know your enic diet I I think you have to pay very close attention to if your if your lipids get out of whack”

0.69

Carbohydrate restriction, particularly restriction of refined and starchy carbohydrates, is the most effective dietary intervention for reducing triglycerides, and triglyceride reduction is a major proxy for improving insulin sensitivity and lowering ApoB.

causalhigh valueestablishednovelty 1/4durability 3/4· Unknown Speaker (Medical Professional)

“it's pretty clearly observed from a dietary pattern perspective that carbohydrate restriction is the most effective tool of triglyceride reduction all carbohydrates I mean like vegetables fruits F yeah refined and starchy carbohydrates”

0.69

The four major causal drivers of atherosclerotic cardiovascular disease are: (1) ApoB, (2) insulin resistance, (3) hypertension, and (4) smoking; all four must be considered in total risk assessment, and lowering ApoB alone does not confer protection if other major drivers remain uncontrolled.

factualhigh valueestablishednovelty 1/4durability 3/4· Unknown Speaker (Medical Professional)

“there are really four big things that are driving risk causally apob is one insulin resistance is one hypertension is one and smoking is one those are the Big Four so you have to take everything we're saying on the apob front and acknowledge that those other things are also causally linked to asbd so again it's it's a difficult situation to imagine but it's certainly at least theoretically plausible you have somebody whose apob is at 60 but they have uncontrolled hypertension type 2 diabetes and they smoke I mean you could certainly arrive at that situation pharmacologically you're probably not going to arrive at that situation naturally um would I say that that person is free clear no I wouldn't”

0.68

ApoB rises with age in adult populations, primarily due to reduced clearance of ApoB particles rather than increased synthesis; this is likely driven by declining LDL receptor number or reduced LDL receptor lifespan, rather than changes in endocrine function or insulin resistance alone.

causalhigh valuecontestednovelty 2/4durability 3/4· Unknown Speaker (Medical Professional)

“apob Rises with age right um we don't really know there are probably a lot of little reasons um so there are you know endocrine changes insulin resistance um sence that you know might involve the uh decreased uh life of LDL receptors... my intuition is yes my intuition is that it's it's it's primarily impacted on the clearance level which is going to be again some facet of ldlr ldlr beating LDL receptor so is it we are making less of them they are surviving less uh the proteins that you know and and that can basically done there there are many ways to regulate that process”

0.68

Different saturated fats may have different potencies for raising cholesterol synthesis; palmitic acid (C16) may be more stimulatory than longer-chain saturated fats (C18, C19), and palmitic acid is found predominantly in coconut oil, palm oil, and is also synthesized de novo in response to insulin resistance.

factualhigh valuecontestednovelty 2/4durability 3/4· Unknown Speaker (Medical Professional)

“saturated fats have a greater impact on cholesterol synthesis uh relative to others for example a c16 might be potentially more so than a c18 or a c19 but again what foods would you find a c16 version oh like a c16 would be more in I believe like a coconut oil or a palm oil or something like that also by the way that you would also see that more a c16 like a palmitate would be more of a synthes would be more of a saturated fat you see in response to insulin resistance”

0.65

LDL particles carry both cholesterol and triglyceride as cargo; higher triglyceride burden requires more LDL particles (more ApoB) to transport the same amount of cholesterol, so two people with identical LDL cholesterol levels but different triglyceride levels will have markedly different ApoB and ASCVD risk.

causalhigh valueestablishednovelty 1/4durability 3/4· Unknown Speaker (Primary)

“the LDL is C carrying around both cholesterol and triglyceride and the more cholesterol there is all things equal the more LDL you need but the same is true with triglyceride so the first mechanism in which we see a very clear relationship between diet and apob is the higher the burden of triglycerides the higher the burden of apob to State this another way if you take two people who have the exact same level of LDL cholesterol in the same total cholesterol but one has very high triglycerides and one has very low triglycerides the former is going to have a much higher apob and therefore be at a much higher risk of atherosclerosis because they have more cargo and therefore require more ships”

0.64

Atherosclerotic cardiovascular disease is the leading cause of death globally, responsible for approximately 19 million deaths annually, compared to approximately 12-13 million for cancer, representing a substantially larger burden of mortality than cancer despite less public awareness.

factualhigh valueestablishednovelty 1/4durability 2/4· Unknown Speaker (Medical Professional)

“when you talk about it globally the gap between asbd and cancer is even bigger it's like 19 million people annually to 12 or 13 million for cancer I mean it's an enormous difference”

0.63

Understanding the mechanisms that cause atherosclerotic cardiovascular disease is now clear, and the tools for prevention are among the best and most benign available in medicine, making ASCVD one of the most preventable major causes of death.

normativehigh valueestablishednovelty 0/4durability 3/4· Unknown Speaker 1

“the good news is our understanding mechanistically of what drives this is so clear and our tools for prevention are some of the best and most benign”

0.56

Saturated fat consumption directly increases cholesterol synthesis in the body through effects independent of dietary cholesterol intake, making it a second major dietary driver of ApoB elevation.

causalhigh valueestablishednovelty 1/4durability 2/4· Unknown Speaker 1

“the next dietary pattern that impacts apob and that saturated fat consumption and the reasons for that are twofold so the first is that saturated fat directly impacts cholesterol synthesis”

0.52

The evolutionary cost of cholesterol synthesis is enormous, requiring approximately 40 ATP molecules per cholesterol molecule, making it energetically expensive to produce; this was conserved as an advantage when energy was scarce but now serves no benefit in the modern energy-abundant environment.

causalhigh valuespeaker onlynovelty 2/4durability 3/4· Unknown Speaker (Primary)

“the evolutionary cost of making cholesterol is enormous uh I mean it's a very labor intensive step right I I can't remember the number of atps that are required to make a molecule of cholesterol but it's in the tens right like it could could be 40 or something to that effect and so we evolved to have a system that prioritized having a lot of cholesterol being able to keep a lot of it around um because again this was an energy conserving system now this serves us no benefit today because to we can make plenty of it and we are we are in an energy abundant environment which we were not in you know hundreds of thousands of years ago”

0.47

VLDL particles are constantly synthesized by the liver and exported; from an evolutionary perspective, VLDL evolved to transport not only cholesterol, triglycerides, and fatty acids but also inflammatory proteins like C-reactive protein, which was beneficial for immune response before the modern antibiotic and antiviral era, making current high VLDL production a vestigial trait no longer serving adaptive function.

causalhigh valuespeaker onlynovelty 2/4durability 3/4· Unknown Speaker (Medical Professional)

“the the thing is is that you know he was saying well from an evolutionary perspective um you're you're making this vldl because as you mentioned you know it's transporting things throughout the body to other organs right cholesterol Tri triglycerides fatty acids it's also transporting and this is where I was so intrigued inflammatory protein so cyto ctive protein also are being transported through vldl now that was important pre antibiotics pre everything that we do now to combat you know infectious disease and viruses and bacteria parasites whatever um but before that time that vldl did serve that purpose too and that's why he thinks you know it's kind of a relic left over where the reason why we're constantly making is because”

0.45

Most people cannot achieve ApoB levels below 30 mg/dL through diet and lifestyle alone; pharmacologic intervention is typically required, making pharmaceutical management a necessary component of aggressive atherosclerosis prevention.

factualhigh valuespeaker onlynovelty 1/4durability 2/4· Unknown Speaker 1

“most people cannot get down to 30 without without a pharmacologic intervention”

0.43

The speaker followed a ketogenic diet for 3 years with approximately 80% of calories from fat (roughly 50% of calories from saturated fat) without experiencing a problematic increase in ApoB or LDL cholesterol, indicating genetic variation in individual susceptibility to saturated fat-induced lipid elevation.

factualhigh valuespeaker onlynovelty 1/4durability 3/4· Unknown Speaker (Medical Professional)

“I think cholesterol synthesis big part of it I think a bigger part of it might be that excess saturated fat inhibits this sterile binding the sterile regulatory binding protein in the liver that results in fewer LDL uh receptors being made so saturated fat therefore has two things that it's doing that are driving up apob and the susceptibility of this varies from different individuals so um I was on a ketogenic diet for 3 years I was not one of the people who seemed to suffer from this so even on a ketogenic diet where I was getting 80% of my calories from fat and probably half of that was saturated fat I did not have any sort of obnoxious increase in my apob or ldlc”

0.17

The speaker's understanding of ApoB mechanisms and the importance of aggressive ApoB lowering is the subject of substantial discussion in a book they have written, indicating this is a central thesis of their published work.

factualspeaker onlynovelty 0/4durability 2/4· Unknown Speaker (Medical Professional)

“I write I devote actually quite a bit of real estate to this in the book because I think it is such an important concept”